Live Breaking News & Updates on Clarus Therapeutics Holdings Inc

Stay updated with breaking news from Clarus therapeutics holdings inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Critical Comparison: Tarsus Pharmaceuticals (NASDAQ:TARS) vs. Clarus Therapeutics (OTCMKTS:CRXTQ)

Clarus Therapeutics (OTCMKTS:CRXTQ – Get Free Report) and Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Analyst Recommendations This is a breakdown of current […] ....

United States , Tarsus Pharmaceuticals Inc , Tarsus Pharmaceuticals , Clarus Therapeutics Holdings Inc , Clarus Therapeutics , Get Free Report , Given Tarsus Pharmaceutical , Tarsus Pharmaceutical , Therapeutics Holdings , Havah Therapeutics , Royal Institution , Mcgill University , Clarus Therapeutics Daily , Otcmkts Crxtq , Stock Comparison , Stock Analysis ,

Financial Analysis: Clarus Therapeutics (OTCMKTS:CRXTQ) and AVROBIO (NASDAQ:AVRO)

AVROBIO (NASDAQ:AVRO – Get Free Report) and Clarus Therapeutics (OTCMKTS:CRXTQ – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability. Institutional & Insider Ownership 60.0% of AVROBIO shares […] ....

United States , United Kingdom , Avrobio Inc , Clarus Therapeutics Holdings Inc , Get Free Report , Clarus Therapeutics , Clarus Therapeutic , Therapeutics Holdings , Havah Therapeutics , Royal Institution , Mcgill University , Nasdaq Avro , Stock Comparison , Stock Analysis ,

Analyzing ImmunityBio (NASDAQ:IBRX) & Clarus Therapeutics (OTCMKTS:CRXTQ)

Clarus Therapeutics (OTCMKTS:CRXTQ – Get Free Report) and ImmunityBio (NASDAQ:IBRX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation. Profitability This table compares Clarus Therapeutics and ImmunityBio’s […] ....

United States , San Diego , Access To Advanced Health Institute , National Cancer Institute , Sorrento Therapeutics Inc , Viracta Therapeutics Inc , Shenzhen Beike Biotechnology Co , Sanford Health , Clarus Therapeutics Holdings Inc , Immunitybio Inc , M Innovative Properties Company , Ladrx Corporation , Globeimmune Inc , Amyris Inc , Clarus Therapeutics , Get Free Report , Given Immunitybio , Therapeutics Holdings , Havah Therapeutics , Royal Institution , Mcgill University , Advanced Health Institute , Innovative Properties Company , Shenzhen Beike Biotechnology , Sorrento Therapeutics , Viracta Therapeutics ,

Clarus Therapeutics (OTCMKTS:CRXTQ) and Innate Pharma (OTCMKTS:IPHYF) Head-To-Head Survey

Clarus Therapeutics (OTCMKTS:CRXTQ – Get Rating) and Innate Pharma (OTCMKTS:IPHYF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Volatility and Risk Clarus Therapeutics has a beta of […] ....

United States , Eric Vivier , Marc Bonneville , Jean Jacques Fourni , Alessandro Moretta , Eloi Dominique Brailly , Clarus Therapeutics Holdings Inc , Clarus Therapeutics , Get Rating , Innate Pharma , Therapeutics Holdings , Havah Therapeutics , Royal Institution , Mcgill University , Clarus Therapeutics Daily , Otcmkts Crxtq , Stock Comparison , Stock Analysis ,

Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio

- Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years - JATENZO is an oral softgel. ....

United States , Buffalo Grove , Julie Ferguson , Todd Smith , Us Bankruptcy Court , Company Contact , Men Health , Tolmar Pharmaceuticals Inc , Faegre Drinker Biddle Reath , Clarus Therapeutics Inc , Clarus Therapeutics Holdings Inc , Prnewswire Tolmar Pharmaceuticals Inc , Tolmar Pharmaceuticals , Tolmar Inc , Orphan Diseases , Clarus Therapeutics Holdings , Clarus Therapeutics , Anild Souza , Chief Executive Officer , Chief Commercial Officer , Faegre Drinker Biddle , Northern Colorado , North America , Prescribing Information , Health Care Amp Hospitals , Medical Pharmaceuticals ,